openPR Logo
Press release

Antineoplastic Agents Market 2016-2024: by Product Type, End User, by Geography and Company Profile

Antineoplastic Agents Market

Antineoplastic Agents Market

The second major cause of death in U.S. is Cancer after cardiovascular diseases and is expected to ascend becoming the leading cause of death in next few years. According to Center for Disease Control and Prevention (CDC), malignant neoplasms accounted for 15% of deaths worldwide in 2012 with 19.3 Mn new cases of cancer are expected to be diagnosed by 2025. The increasing number is a major challenge to physicians and researchers to fulfill the unmet needs in treatment of malignant neoplasms. Anti-neoplastic agents are used prominently as a first line therapy for cancer treatment as well as in combination with surgery or radiation therapy. Plenty of anti-neoplastic agents are available commercially for the treatment of different types of cancers including Oncotrex, Gleevec, Neosar, Cytarine, Leukeran etc. Several new anti-neoplastic agents are in clinical trials such as Oncofetal Ag (phase 1), Panobinostat (Phase 2), Volasertib (phase 2), Bortezomib (phase 4) etc. which are expected to launch in next 5-10 years.

Read Report @ https://www.persistencemarketresearch.com/market-research/antineoplastic-agents-market.asp

Factors such as growing incidence of cancer across the globe and demand for cost-effective treatment options are believed to play crucial role for the growth of global anti-neoplastic agents market. Rapid innovation in the field of personalized medicine presents a huge opportunity to manufacturers of anti-neoplastic agents. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global anti-neoplastic agents market.

Increasing investment by multinational companies in cancer research owing to increasing prevalence of cancer is expected to boost the global market for anti-neoplastic agents during the forecast period. Based on product type, anti-neoplastic agents are classified as chemotherapeutic agents, biological or immunotherapeutic agents and personalized medicine. Chemotherapeutic agents segment is foreseen to lead the market owing to easy availability of drugs and immunotherapeutic agents segment is expected grow rapidly due to increasing acceptance of biological therapy owing to lesser side effects.

On the basis of end user, the global chemotherapeutic agents market has been segmented into hospitals, Clinics, cancer rehabilitation center and ambulatory surgical centers. Hospital end user segment is anticipated to contribute the maximum share among end users. As per the statistics given by The Healthcare Cost and Utilization Project (H-CUP), there were 4.7 Mn hospitalizations related to cancer in U.S. in year 2009 and about 6% of adult inpatient hospital cost was generated by hospitalization of cancer patients.

Request Sample Report @ https://www.persistencemarketresearch.com/samples/10741

On the basis of regional presence, anti-neoplastic agents market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America will continue to dominate the global anti-neoplastic agents market for due to high prevalence of malignant neoplasm. Europe is expected to hold second largest market share in global anti-neoplastic agents market. In 2013, as per Cancer Research UK, 605 people per 100,000 general population were diagnosed with cancer.

Some of the major players in global anti-neoplastic agents market include Hoffmann-La Roche Ltd., Amgen Inc., Bristol-Myers Squibb Company, Baxter Healthcare Corporation, Boehringer Ingelheim GmbH, Aspen Global Inc., Bayer AG, Teva pharmaceutical Industries Ltd., Johnson & Johnson Pvt. Ltd., Merc & Co., Inc., Pfize Inc., Accord Healthcare, Inc., Genentech, Inc., Lundbeck LLC, AbbVie Inc. and others.

Buy now @ https://www.persistencemarketresearch.com/checkout/10741

About Us

Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.

PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.

Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: https://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Antineoplastic Agents Market 2016-2024: by Product Type, End User, by Geography and Company Profile here

News-ID: 842504 • Views:

More Releases from Persistance Market Research

Evolving Trends in the Insulin Pens Market: A Comprehensive Report
Evolving Trends in the Insulin Pens Market: A Comprehensive Report
Market Overview: The Insulin Pens Market has witnessed remarkable growth and innovation over the years. Insulin pens are medical devices used by individuals with diabetes to administer insulin easily and accurately. These devices have become an integral part of diabetes management, offering numerous advantages over traditional insulin delivery methods, such as syringes and vials. In 2022, the global market for insulin pens brought in US$ 16.2 billion in revenue and is predicted
Smart Machines Market to register growth at a CAGR of 20.1% throughout 2023-2033
The market for smart machines was valued at US$ 73,456.2 Mn in 2022, and it is expected to grow to US$ 5,44,986.6 Mn by the end of 2033. In 2023, the market for smart machines is expected to be worth US$ 87,045.6 Mn. From 2023 to 2033, the market for Smart Machines is expected to grow at a CAGR of 20.1%. The market for artificially intelligent machines and systems that can
Unified Cloud Communication and Collaboration Market will register a 11.1% CAGR by 2032
Unified Cloud Communication and Collaboration Market will register a 11.1% CAGR …
The global cloud collaboration market was valued at US$ 48 billion in 2022, and it is expected to grow at an 11.1% CAGR, likely reaching US$ 137.3 billion by the end of the forecast period, which runs from 2022 to 2032. The expansion of organizations' cross-border projects, increased productivity, and the rise of the bring your own device (BYOD) trend are some of the major factors expected to drive the
Optical Transceivers Market is Set to Grow At A CAGR Of 14.6 % By 2032
Optical Transceivers Market is Set to Grow At A CAGR Of 14.6 % By 2032
Persistence Market Research's new report "Optical Transceivers Market" examines the competitive landscape and the market's growth prospects in the coming years. The report of the Optical Transceivers market for the analysis period of 2023 - 2033 includes an in-depth study of some new and prominent industry trends, engagement analysis, and detailed regional analysis. Need More Insights on Competitor Analysis of the Smart Home Cloud Platform Market, Request for Sample https://www.persistencemarketresearch.com/samples/4798 Through

All 5 Releases


More Releases for Antineoplastic

Antineoplastic Interferon Drug Market By Equipment, Application, By Region, Anal …
The Antineoplastic Interferon Drug Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. Antineoplastic interferon drug are the agents promising therapeutic approaches for the treatment of
Antineoplastic Interferon Drug Market Size and Drivers is Responsible to for Inc …
The Antineoplastic Interferon Drug Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. Antineoplastic interferon drug are the agents promising therapeutic approaches for the treatment of
Antineoplastic Agents Market is Set to Experience Revolutionary Growth by 2026
ENT surgical instruments are used to treat simple and complex disorders related to ear, nose and throat and are consist of various medical devices namely Radiofrequency Devices, Hand instruments, ENT powered instruments. With increasing prevalence of chronic sinusitis and airway obstructive disorder, these endoscopic surgery is the treatment of choice as medical therapy fails provide complete relief to the patients. To overcome these problem surgical interventions are required. Powered surgical
Antineoplastic Agents Market to Witness an Outstanding Growth by 2024
The second major cause of death in U.S. is Cancer after cardiovascular diseases and is expected to ascend becoming the leading cause of death in next few years. According to Center for Disease Control and Prevention (CDC), malignant neoplasms accounted for 15% of deaths worldwide in 2012 with 19.3 Mn new cases of cancer are expected to be diagnosed by 2025. The increasing number is a major challenge to physicians
Global Antineoplastic Drugs Market Analysis, Overview, Sales and Industry Demand …
A fresh report has been added to the wide database of Market Research Hub (MRH) titled “Global Antineoplastic Drugs Market Research Report (2018-2025)” which provides an outlook of current market value as well as the expected forecast of Rate on Investment (ROI) with growing CAGR of XX% by the end of 2025. The report also studies the Antineoplastic Drugs market worldwide, especially in North America, China, Europe, Southeast Asia, Japan
Global Antineoplastic Drugs Market Analysis – Future Trends, Opportunities, Si …
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Global Antineoplastic Drugs Market Professional Survey Report 2017”, report studies Antineoplastic Drugs in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. Request For Free Sample Report: https://www.marketresearchhub.com/enquiry.php?type=S&repid=1359726 This report focuses